Target Gene/Pathway💬 Info on mouse-over

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	Disease ID
1	Acute myeloid leukemia 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
2	Acute myeloid leukemia 💬	[4] BRAF, FLT3, KIT, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
3	Acute myeloid leukemia 💬	[4] BRAF, FLT3, KIT, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
4	Acute myeloid leukemia 💬	[2] FLT3, KIT 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
5	Acute myeloid leukemia 💬	[2] FLT3, KIT 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
6	Acute myeloid leukemia 💬	[1] KIT 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
7	Acute myeloid leukemia 💬	[1] KIT 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
8	Acute myeloid leukemia 💬	[1] KIT 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
9	Acute myeloid leukemia 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
10	Acute myeloid leukemia 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
11	Acute myeloid leukemia 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
12	Acute myeloid leukemia 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
13	Acute myeloid leukemia 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
14	Acute myeloid leukemia 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
15	Adherens junction 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
16	Adherens junction 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
17	Adherens junction 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
18	Adherens junction 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
19	Adherens junction 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
20	Adipocytokine signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
21	Adipocytokine signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
22	Adipocytokine signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
23	Adipocytokine signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
24	Adipocytokine signaling pathway 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
25	Adipocytokine signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
26	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬	D00354 💬	Lamotrigine	[5] 13, 34, 38, 114, 144 💬
27	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬	D00358 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
28	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬	D02086 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
29	Adrenergic signaling in cardiomyocytes 💬	[1] SCN5A 💬	D08127 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
30	African trypanosomiasis 💬	[4] IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
31	African trypanosomiasis 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
32	African trypanosomiasis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
33	AGE-RAGE signaling pathway in diabetic complications 💬	[5] CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
34	AGE-RAGE signaling pathway in diabetic complications 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
35	AGE-RAGE signaling pathway in diabetic complications 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
36	AGE-RAGE signaling pathway in diabetic complications 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
37	AGE-RAGE signaling pathway in diabetic complications 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
38	Alanine, aspartate and glutamate metabolism 💬	[4] ABAT, ALDH5A1, GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
39	Alcoholism 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
40	Alcoholism 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
41	Alcoholism 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
42	Alcoholism 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
43	Alcoholism 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
44	Alcoholism 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
45	Alcoholism 💬	[1] SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
46	Alcoholism 💬	[1] SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
47	Aldosterone synthesis and secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
48	Allograft rejection 💬	[2] IL10, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
49	Allograft rejection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
50	Allograft rejection 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
51	Alzheimer disease 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
52	Alzheimer disease 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
53	Alzheimer disease 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
54	Alzheimer disease 💬	[1] CSF1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
55	Alzheimer disease 💬	[1] CSF1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
56	Alzheimer disease 💬	[4] IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
57	Alzheimer disease 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
58	Alzheimer disease 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
59	Alzheimer disease 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
60	Alzheimer disease 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
61	Alzheimer disease 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
62	Alzheimer disease 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
63	Alzheimer disease 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
64	Alzheimer disease 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
65	Alzheimer disease 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
66	Alzheimer disease 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
67	Alzheimer disease 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
68	Alzheimer disease 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
69	Alzheimer disease 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
70	Alzheimer disease 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
71	Alzheimer disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
72	Alzheimer disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
73	Alzheimer disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
74	Alzheimer disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
75	Amoebiasis 💬	[4] IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
76	Amoebiasis 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
77	Amoebiasis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
78	Amphetamine addiction 💬	[1] SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
79	Amphetamine addiction 💬	[1] SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
80	AMPK signaling pathway 💬	[1] HMGCR 💬	D00359 💬	Lovastatin	[11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
81	AMPK signaling pathway 💬	[1] HMGCR 💬	D00434 💬	Simvastatin	[21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
82	AMPK signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
83	AMPK signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
84	AMPK signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
85	Amyotrophic lateral sclerosis 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
86	Amyotrophic lateral sclerosis 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
87	Amyotrophic lateral sclerosis 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
88	Amyotrophic lateral sclerosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
89	Amyotrophic lateral sclerosis 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
90	Amyotrophic lateral sclerosis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
91	Amyotrophic lateral sclerosis 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
92	Amyotrophic lateral sclerosis 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
93	Amyotrophic lateral sclerosis 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
94	Amyotrophic lateral sclerosis 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
95	Antifolate resistance 💬	[2] DHFR, DHFR2 💬	D00142 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
96	Antifolate resistance 💬	[2] DHFR, DHFR2 💬	D02115 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
97	Antifolate resistance 💬	[3] IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
98	Antifolate resistance 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
99	Antifolate resistance 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
100	Antigen processing and presentation 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
101	Antigen processing and presentation 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102	Antigen processing and presentation 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
103	Apelin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
104	Apelin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
105	Apelin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
106	Apelin signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
107	Apelin signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
108	Apelin signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
109	Apelin signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
110	Apelin signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
111	Apoptosis 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
112	Apoptosis 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
113	Apoptosis 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
114	Apoptosis 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
115	Apoptosis 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
116	Apoptosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
117	Apoptosis 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
118	Apoptosis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
119	Arachidonic acid metabolism 💬	[2] PTGS1, PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
120	Arachidonic acid metabolism 💬	[2] PTGS1, PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
121	Arachidonic acid metabolism 💬	[2] PTGS1, PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
122	Arachidonic acid metabolism 💬	[2] PTGS1, PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
123	Arachidonic acid metabolism 💬	[2] PTGS1, PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
124	Arachidonic acid metabolism 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
125	Asthma 💬	[2] IL10, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
126	Asthma 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
127	Asthma 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
128	Autoimmune thyroid disease 💬	[1] IL10 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
129	Autophagy - animal 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
130	Autophagy - animal 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
131	Autophagy - animal 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
132	Autophagy - animal 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
133	Autophagy - animal 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
134	Autophagy - animal 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
135	Autophagy - animal 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
136	Autophagy - animal 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
137	Autophagy - other 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
138	Autophagy - other 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
139	Autophagy - other 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
140	Axon guidance 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
141	Axon guidance 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
142	Axon guidance 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
143	Axon guidance 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
144	Axon guidance 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
145	Axon guidance 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
146	Axon guidance 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
147	B cell receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
148	B cell receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
149	B cell receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
150	B cell receptor signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
151	B cell receptor signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
152	Bacterial invasion of epithelial cells 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
153	beta-Alanine metabolism 💬	[3] ABAT, GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
154	Bile secretion 💬	[1] HMGCR 💬	D00359 💬	Lovastatin	[11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
155	Bile secretion 💬	[1] HMGCR 💬	D00434 💬	Simvastatin	[21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
156	Biosynthesis of cofactors 💬	[2] DHFR, DHFR2 💬	D00142 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
157	Biosynthesis of cofactors 💬	[2] DHFR, DHFR2 💬	D02115 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
158	Bladder cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
159	Bladder cancer 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
160	Bladder cancer 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
161	Bladder cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
162	Bladder cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
163	Bladder cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
164	Bladder cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
165	Bladder cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
166	Bladder cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
167	Bladder cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
168	Bladder cancer 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
169	Bladder cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
170	Breast cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
171	Breast cancer 💬	[4] BRAF, FLT4, KIT, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
172	Breast cancer 💬	[4] BRAF, FLT4, KIT, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
173	Breast cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
174	Breast cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
175	Breast cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
176	Breast cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
177	Breast cancer 💬	[1] FLT4 💬	D03218 💬	Axitinib	[1] 34 💬
178	Breast cancer 💬	[1] FLT4 💬	D08881 💬	Cediranib	[1] 34 💬
179	Breast cancer 💬	[2] FLT4, KIT 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
180	Breast cancer 💬	[2] FLT4, KIT 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
181	Breast cancer 💬	[1] KIT 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
182	Breast cancer 💬	[1] KIT 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
183	Breast cancer 💬	[1] KIT 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
184	Breast cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
185	Breast cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
186	Breast cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
187	Breast cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
188	Breast cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
189	Breast cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
190	Butanoate metabolism 💬	[4] ABAT, ALDH5A1, GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
191	C-type lectin receptor signaling pathway 💬	[4] IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
192	C-type lectin receptor signaling pathway 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
193	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
194	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
195	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
196	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
197	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
198	C-type lectin receptor signaling pathway 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
199	C-type lectin receptor signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
200	C-type lectin receptor signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
201	C-type lectin receptor signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
202	Calcium signaling pathway 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
203	Calcium signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
204	Calcium signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
205	Calcium signaling pathway 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
206	Calcium signaling pathway 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
207	Calcium signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D03218 💬	Axitinib	[1] 34 💬
208	Calcium signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D08881 💬	Cediranib	[1] 34 💬
209	Calcium signaling pathway 💬	[6] FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
210	Calcium signaling pathway 💬	[6] FLT1, FLT4, KDR, PDGFRA, PDGFRB, RET 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
211	Calcium signaling pathway 💬	[4] FLT4, KDR, PDGFRB, RET 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
212	Calcium signaling pathway 💬	[4] FLT4, KDR, PDGFRB, RET 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
213	Calcium signaling pathway 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
214	Calcium signaling pathway 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
215	Calcium signaling pathway 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
216	Calcium signaling pathway 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
217	Calcium signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
218	Calcium signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
219	cAMP signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
220	cAMP signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
221	cAMP signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
222	cAMP signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
223	cAMP signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
224	cAMP signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
225	Cell cycle 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
226	Cell cycle 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
227	Cell cycle 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
228	Cellular senescence 💬	[2] IL1A, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
229	Cellular senescence 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
230	Cellular senescence 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
231	Cellular senescence 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
232	Cellular senescence 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
233	Cellular senescence 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
234	Cellular senescence 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
235	Cellular senescence 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
236	Cellular senescence 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
237	Cellular senescence 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
238	Central carbon metabolism in cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
239	Central carbon metabolism in cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
240	Central carbon metabolism in cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
241	Central carbon metabolism in cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
242	Central carbon metabolism in cancer 💬	[5] FLT3, KIT, PDGFRA, PDGFRB, RET 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
243	Central carbon metabolism in cancer 💬	[5] FLT3, KIT, PDGFRA, PDGFRB, RET 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
244	Central carbon metabolism in cancer 💬	[5] FLT3, KIT, PDGFRB, RAF1, RET 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
245	Central carbon metabolism in cancer 💬	[5] FLT3, KIT, PDGFRB, RAF1, RET 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
246	Central carbon metabolism in cancer 💬	[2] KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
247	Central carbon metabolism in cancer 💬	[2] KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
248	Central carbon metabolism in cancer 💬	[3] KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
249	Central carbon metabolism in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
250	Central carbon metabolism in cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
251	Central carbon metabolism in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
252	Central carbon metabolism in cancer 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
253	Central carbon metabolism in cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
254	Central carbon metabolism in cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
255	Central carbon metabolism in cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
256	cGMP-PKG signaling pathway 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬	D00514 💬	Dexmedetomidine	[12]  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
257	cGMP-PKG signaling pathway 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬	D01205 💬	Dexmedetomidine	[12]  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
258	cGMP-PKG signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
259	cGMP-PKG signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
260	cGMP-PKG signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
261	cGMP-PKG signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
262	cGMP-PKG signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
263	Chagas disease 💬	[5] CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
264	Chagas disease 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
265	Chagas disease 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
266	Chemical carcinogenesis 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
267	Chemical carcinogenesis 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
268	Chemical carcinogenesis 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
269	Chemical carcinogenesis 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
270	Chemical carcinogenesis 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
271	Chemical carcinogenesis 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
272	Chemokine signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
273	Chemokine signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
274	Chemokine signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
275	Chemokine signaling pathway 💬	[1] CCL2 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
276	Chemokine signaling pathway 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
277	Chemokine signaling pathway 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
278	Chemokine signaling pathway 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
279	Choline metabolism in cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
280	Choline metabolism in cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
281	Choline metabolism in cancer 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
282	Choline metabolism in cancer 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
283	Choline metabolism in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
284	Choline metabolism in cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
285	Choline metabolism in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
286	Choline metabolism in cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
287	Choline metabolism in cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
288	Choline metabolism in cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
289	Choline metabolism in cancer 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
290	Choline metabolism in cancer 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
291	Choline metabolism in cancer 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
292	Choline metabolism in cancer 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
293	Choline metabolism in cancer 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
294	Choline metabolism in cancer 💬	[2] PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
295	Choline metabolism in cancer 💬	[2] PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
296	Cholinergic synapse 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
297	Cholinergic synapse 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
298	Cholinergic synapse 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
299	Chronic myeloid leukemia 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
300	Chronic myeloid leukemia 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
301	Chronic myeloid leukemia 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
302	Chronic myeloid leukemia 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
303	Chronic myeloid leukemia 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
304	Chronic myeloid leukemia 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
305	Chronic myeloid leukemia 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
306	Chronic myeloid leukemia 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
307	Chronic myeloid leukemia 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
308	Circadian entrainment 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
309	Cocaine addiction 💬	[1] SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
310	Cocaine addiction 💬	[1] SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
311	Colorectal cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
312	Colorectal cancer 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
313	Colorectal cancer 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
314	Colorectal cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
315	Colorectal cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
316	Colorectal cancer 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
317	Colorectal cancer 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
318	Colorectal cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
319	Colorectal cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
320	Colorectal cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
321	Colorectal cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
322	Colorectal cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
323	Colorectal cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
324	Coronavirus disease - COVID-19 💬	[4] CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
325	Coronavirus disease - COVID-19 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
326	Coronavirus disease - COVID-19 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
327	Coronavirus disease - COVID-19 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
328	Coronavirus disease - COVID-19 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
329	Coronavirus disease - COVID-19 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
330	Coronavirus disease - COVID-19 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
331	Coronavirus disease - COVID-19 💬	[1] TLR7 💬	D02500 💬	Imiquimod	[2] 34, 51 💬
332	Coronavirus disease - COVID-19 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
333	Cortisol synthesis and secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
334	Cushing syndrome 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
335	Cushing syndrome 💬	[1] BRAF 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
336	Cushing syndrome 💬	[1] BRAF 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
337	Cushing syndrome 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
338	Cushing syndrome 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
339	Cushing syndrome 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
340	Cushing syndrome 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
341	Cushing syndrome 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
342	Cushing syndrome 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
343	Cushing syndrome 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
344	Cushing syndrome 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
345	Cytokine-cytokine receptor interaction 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
346	Cytokine-cytokine receptor interaction 💬	[6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
347	Cytokine-cytokine receptor interaction 💬	[1] CSF1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
348	Cytokine-cytokine receptor interaction 💬	[1] CSF1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
349	Cytokine-cytokine receptor interaction 💬	[1] CSF3R 💬	D03235 💬	Filgrastim	[33]  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
350	Cytokine-cytokine receptor interaction 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
351	Cytokine-cytokine receptor interaction 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
352	Cytokine-cytokine receptor interaction 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
353	Cytosolic DNA-sensing pathway 💬	[2] IL1B, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
354	Cytosolic DNA-sensing pathway 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
355	Diabetic cardiomyopathy 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
356	Diabetic cardiomyopathy 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
357	Diabetic cardiomyopathy 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
358	Dilated cardiomyopathy 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
359	Dilated cardiomyopathy 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
360	Dilated cardiomyopathy 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
361	Dopaminergic synapse 💬	[1] SCN1A 💬	D00354 💬	Lamotrigine	[5] 13, 34, 38, 114, 144 💬
362	Dopaminergic synapse 💬	[1] SCN1A 💬	D00358 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
363	Dopaminergic synapse 💬	[1] SCN1A 💬	D02086 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
364	Dopaminergic synapse 💬	[1] SCN1A 💬	D08127 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
365	Dopaminergic synapse 💬	[1] SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
366	Dopaminergic synapse 💬	[1] SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
367	EGFR tyrosine kinase inhibitor resistance 💬	[3] AXL, KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
368	EGFR tyrosine kinase inhibitor resistance 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
369	EGFR tyrosine kinase inhibitor resistance 💬	[4] BRAF, KDR, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
370	EGFR tyrosine kinase inhibitor resistance 💬	[4] BRAF, KDR, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
371	EGFR tyrosine kinase inhibitor resistance 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
372	EGFR tyrosine kinase inhibitor resistance 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
373	EGFR tyrosine kinase inhibitor resistance 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
374	EGFR tyrosine kinase inhibitor resistance 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
375	EGFR tyrosine kinase inhibitor resistance 💬	[1] IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
376	EGFR tyrosine kinase inhibitor resistance 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
377	EGFR tyrosine kinase inhibitor resistance 💬	[1] KDR 💬	D03218 💬	Axitinib	[1] 34 💬
378	EGFR tyrosine kinase inhibitor resistance 💬	[1] KDR 💬	D08881 💬	Cediranib	[1] 34 💬
379	EGFR tyrosine kinase inhibitor resistance 💬	[3] KDR, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
380	EGFR tyrosine kinase inhibitor resistance 💬	[3] KDR, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
381	EGFR tyrosine kinase inhibitor resistance 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
382	EGFR tyrosine kinase inhibitor resistance 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
383	EGFR tyrosine kinase inhibitor resistance 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
384	EGFR tyrosine kinase inhibitor resistance 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
385	EGFR tyrosine kinase inhibitor resistance 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
386	EGFR tyrosine kinase inhibitor resistance 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
387	EGFR tyrosine kinase inhibitor resistance 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
388	EGFR tyrosine kinase inhibitor resistance 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
389	EGFR tyrosine kinase inhibitor resistance 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
390	EGFR tyrosine kinase inhibitor resistance 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
391	EGFR tyrosine kinase inhibitor resistance 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
392	Endocrine and other factor-regulated calcium reabsorption 💬	[1] VDR 💬	D00188 💬	Cholecalciferol	[23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
393	Endocrine resistance 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
394	Endocrine resistance 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
395	Endocrine resistance 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
396	Endocrine resistance 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
397	Endocrine resistance 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
398	Endocrine resistance 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
399	Endocrine resistance 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
400	Endocrine resistance 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
401	Endocrine resistance 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
402	Endocrine resistance 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
403	Endocrine resistance 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
404	Endocrine resistance 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
405	Endocrine resistance 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
406	Endocytosis 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
407	Endocytosis 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
408	Endocytosis 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
409	Endocytosis 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
410	Endocytosis 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
411	Endocytosis 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
412	Endocytosis 💬	[1] PDGFRA 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
413	Endocytosis 💬	[1] PDGFRA 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
414	Endocytosis 💬	[1] PDGFRA 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
415	Endometrial cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
416	Endometrial cancer 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
417	Endometrial cancer 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
418	Endometrial cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
419	Endometrial cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
420	Endometrial cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
421	Endometrial cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
422	Endometrial cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
423	Endometrial cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
424	Endometrial cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
425	Epithelial cell signaling in Helicobacter pylori infection 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
426	Epithelial cell signaling in Helicobacter pylori infection 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
427	Epithelial cell signaling in Helicobacter pylori infection 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
428	Epithelial cell signaling in Helicobacter pylori infection 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
429	Epithelial cell signaling in Helicobacter pylori infection 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
430	Epstein-Barr virus infection 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
431	Epstein-Barr virus infection 💬	[2] IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
432	Epstein-Barr virus infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
433	Epstein-Barr virus infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
434	ErbB signaling pathway 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
435	ErbB signaling pathway 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
436	ErbB signaling pathway 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
437	ErbB signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
438	ErbB signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
439	ErbB signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
440	ErbB signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
441	ErbB signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
442	ErbB signaling pathway 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
443	ErbB signaling pathway 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
444	ErbB signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
445	ErbB signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
446	ErbB signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
447	ErbB signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
448	ErbB signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
449	ErbB signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
450	Estrogen signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
451	Estrogen signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
452	Estrogen signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
453	Estrogen signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
454	Estrogen signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
455	Estrogen signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
456	Estrogen signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
457	Estrogen signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
458	Estrogen signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
459	Fc epsilon RI signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
460	Fc epsilon RI signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
461	Fc epsilon RI signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
462	Fc epsilon RI signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
463	Fc epsilon RI signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
464	Fc epsilon RI signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
465	Fc epsilon RI signaling pathway 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
466	Fc epsilon RI signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
467	Fc gamma R-mediated phagocytosis 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
468	Fc gamma R-mediated phagocytosis 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
469	Fc gamma R-mediated phagocytosis 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
470	Fc gamma R-mediated phagocytosis 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
471	Fc gamma R-mediated phagocytosis 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
472	Fluid shear stress and atherosclerosis 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
473	Fluid shear stress and atherosclerosis 💬	[4] CCL2, IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
474	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D03218 💬	Axitinib	[1] 34 💬
475	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D10062 💬	Cabozantinib	[1] 34 💬
476	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D08881 💬	Cediranib	[1] 34 💬
477	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
478	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
479	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
480	Fluid shear stress and atherosclerosis 💬	[1] KDR 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
481	Fluid shear stress and atherosclerosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
482	Fluid shear stress and atherosclerosis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
483	Fluid shear stress and atherosclerosis 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
484	Fluid shear stress and atherosclerosis 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
485	Focal adhesion 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
486	Focal adhesion 💬	[5] BRAF, FLT4, KDR, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
487	Focal adhesion 💬	[5] BRAF, FLT4, KDR, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
488	Focal adhesion 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
489	Focal adhesion 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
490	Focal adhesion 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
491	Focal adhesion 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
492	Focal adhesion 💬	[3] FLT1, FLT4, KDR 💬	D03218 💬	Axitinib	[1] 34 💬
493	Focal adhesion 💬	[3] FLT1, FLT4, KDR 💬	D08881 💬	Cediranib	[1] 34 💬
494	Focal adhesion 💬	[5] FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
495	Focal adhesion 💬	[5] FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
496	Focal adhesion 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
497	Focal adhesion 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
498	Focal adhesion 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
499	Focal adhesion 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
500	Focal adhesion 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
501	Focal adhesion 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
502	Focal adhesion 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
503	Focal adhesion 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
504	Focal adhesion 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
505	Folate biosynthesis 💬	[2] DHFR, DHFR2 💬	D00142 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
506	Folate biosynthesis 💬	[2] DHFR, DHFR2 💬	D02115 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
507	FoxO signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
508	FoxO signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
509	FoxO signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
510	FoxO signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
511	FoxO signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
512	FoxO signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
513	FoxO signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
514	FoxO signaling pathway 💬	[2] IL10, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
515	FoxO signaling pathway 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
516	FoxO signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
517	FoxO signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
518	FoxO signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
519	GABAergic synapse 💬	[3] ABAT, GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
520	GABAergic synapse 💬	[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
521	Gap junction 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
522	Gap junction 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
523	Gap junction 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
524	Gap junction 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
525	Gap junction 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
526	Gap junction 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
527	Gap junction 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
528	Gap junction 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
529	Gap junction 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
530	Gap junction 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
531	Gap junction 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
532	Gap junction 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
533	Gap junction 💬	[2] PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
534	Gap junction 💬	[2] PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
535	Gap junction 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
536	Gap junction 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
537	Gap junction 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
538	Gap junction 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
539	Gastric cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
540	Gastric cancer 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
541	Gastric cancer 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
542	Gastric cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
543	Gastric cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
544	Gastric cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
545	Gastric cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
546	Gastric cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
547	Gastric cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
548	Gastric cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
549	Gastric cancer 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
550	Gastric cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
551	Gastric cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
552	Gastric cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
553	Glioma 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
554	Glioma 💬	[3] BRAF, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
555	Glioma 💬	[3] BRAF, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
556	Glioma 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
557	Glioma 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
558	Glioma 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
559	Glioma 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
560	Glioma 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
561	Glioma 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
562	Glioma 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
563	Glioma 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
564	Glioma 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
565	Glioma 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
566	Glioma 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
567	Glioma 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
568	Glioma 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
569	Glioma 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
570	Glioma 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
571	GnRH secretion 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
572	GnRH secretion 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
573	GnRH secretion 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
574	GnRH secretion 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
575	GnRH secretion 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
576	GnRH secretion 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
577	GnRH signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
578	GnRH signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
579	GnRH signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
580	GnRH signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
581	GnRH signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
582	GnRH signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
583	GnRH signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
584	GnRH signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
585	GnRH signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
586	Graft-versus-host disease 💬	[4] IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
587	Graft-versus-host disease 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
588	Graft-versus-host disease 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
589	Growth hormone synthesis, secretion and action 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
590	Growth hormone synthesis, secretion and action 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
591	Growth hormone synthesis, secretion and action 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
592	Growth hormone synthesis, secretion and action 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
593	Growth hormone synthesis, secretion and action 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
594	Growth hormone synthesis, secretion and action 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
595	Growth hormone synthesis, secretion and action 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
596	Growth hormone synthesis, secretion and action 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
597	Hematopoietic cell lineage 💬	[3] CSF1, FLT3, KIT 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
598	Hematopoietic cell lineage 💬	[3] CSF1, FLT3, KIT 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
599	Hematopoietic cell lineage 💬	[1] CSF3R 💬	D03235 💬	Filgrastim	[33]  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
600	Hematopoietic cell lineage 💬	[2] FLT3, KIT 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
601	Hematopoietic cell lineage 💬	[2] FLT3, KIT 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
602	Hematopoietic cell lineage 💬	[4] IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
603	Hematopoietic cell lineage 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
604	Hematopoietic cell lineage 💬	[1] KIT 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
605	Hematopoietic cell lineage 💬	[1] KIT 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
606	Hematopoietic cell lineage 💬	[1] KIT 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
607	Hematopoietic cell lineage 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
608	Hepatitis B 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
609	Hepatitis B 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
610	Hepatitis B 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
611	Hepatitis B 💬	[1] IFNAR1 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
612	Hepatitis B 💬	[2] IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
613	Hepatitis B 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
614	Hepatitis B 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
615	Hepatitis B 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
616	Hepatitis B 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
617	Hepatitis B 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
618	Hepatitis C 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
619	Hepatitis C 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
620	Hepatitis C 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
621	Hepatitis C 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
622	Hepatitis C 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
623	Hepatitis C 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
624	Hepatitis C 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
625	Hepatitis C 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
626	Hepatitis C 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
627	Hepatitis C 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
628	Hepatitis C 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
629	Hepatitis C 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
630	Hepatitis C 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
631	Hepatitis C 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
632	Hepatocellular carcinoma 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
633	Hepatocellular carcinoma 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
634	Hepatocellular carcinoma 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
635	Hepatocellular carcinoma 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
636	Hepatocellular carcinoma 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
637	Hepatocellular carcinoma 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
638	Hepatocellular carcinoma 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
639	Hepatocellular carcinoma 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
640	Hepatocellular carcinoma 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
641	Hepatocellular carcinoma 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
642	Hepatocellular carcinoma 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
643	Hepatocellular carcinoma 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
644	Hepatocellular carcinoma 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
645	Hepatocellular carcinoma 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
646	Herpes simplex virus 1 infection 💬	[4] CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
647	Herpes simplex virus 1 infection 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
648	Herpes simplex virus 1 infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
649	Herpes simplex virus 1 infection 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
650	Herpes simplex virus 1 infection 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
651	Herpes simplex virus 1 infection 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
652	Herpes simplex virus 1 infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
653	HIF-1 signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
654	HIF-1 signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
655	HIF-1 signaling pathway 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
656	HIF-1 signaling pathway 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
657	HIF-1 signaling pathway 💬	[1] FLT1 💬	D03218 💬	Axitinib	[1] 34 💬
658	HIF-1 signaling pathway 💬	[1] FLT1 💬	D08881 💬	Cediranib	[1] 34 💬
659	HIF-1 signaling pathway 💬	[1] FLT1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
660	HIF-1 signaling pathway 💬	[1] FLT1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
661	HIF-1 signaling pathway 💬	[1] IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
662	HIF-1 signaling pathway 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
663	HIF-1 signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
664	HIF-1 signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
665	HIF-1 signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
666	HIF-1 signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
667	HIF-1 signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
668	HIF-1 signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
669	HIF-1 signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
670	HIF-1 signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
671	Hippo signaling pathway 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
672	Human cytomegalovirus infection 💬	[4] CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
673	Human cytomegalovirus infection 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
674	Human cytomegalovirus infection 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
675	Human cytomegalovirus infection 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
676	Human cytomegalovirus infection 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
677	Human cytomegalovirus infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
678	Human cytomegalovirus infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
679	Human cytomegalovirus infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
680	Human cytomegalovirus infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
681	Human cytomegalovirus infection 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
682	Human cytomegalovirus infection 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
683	Human cytomegalovirus infection 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
684	Human cytomegalovirus infection 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
685	Human cytomegalovirus infection 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
686	Human cytomegalovirus infection 💬	[1] PDGFRA 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
687	Human cytomegalovirus infection 💬	[1] PDGFRA 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
688	Human cytomegalovirus infection 💬	[1] PDGFRA 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
689	Human cytomegalovirus infection 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
690	Human cytomegalovirus infection 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
691	Human cytomegalovirus infection 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
692	Human cytomegalovirus infection 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
693	Human cytomegalovirus infection 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
694	Human cytomegalovirus infection 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
695	Human cytomegalovirus infection 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
696	Human cytomegalovirus infection 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
697	Human cytomegalovirus infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
698	Human cytomegalovirus infection 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
699	Human cytomegalovirus infection 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
700	Human immunodeficiency virus 1 infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
701	Human immunodeficiency virus 1 infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
702	Human immunodeficiency virus 1 infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
703	Human immunodeficiency virus 1 infection 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
704	Human immunodeficiency virus 1 infection 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
705	Human immunodeficiency virus 1 infection 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
706	Human immunodeficiency virus 1 infection 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
707	Human immunodeficiency virus 1 infection 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
708	Human immunodeficiency virus 1 infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
709	Human immunodeficiency virus 1 infection 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
710	Human immunodeficiency virus 1 infection 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
711	Human papillomavirus infection 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
712	Human papillomavirus infection 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
713	Human papillomavirus infection 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
714	Human papillomavirus infection 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
715	Human papillomavirus infection 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
716	Human papillomavirus infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
717	Human papillomavirus infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
718	Human papillomavirus infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
719	Human papillomavirus infection 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
720	Human papillomavirus infection 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
721	Human papillomavirus infection 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
722	Human papillomavirus infection 💬	[1] PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
723	Human papillomavirus infection 💬	[1] PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
724	Human papillomavirus infection 💬	[1] PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
725	Human papillomavirus infection 💬	[2] PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
726	Human papillomavirus infection 💬	[2] PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
727	Human papillomavirus infection 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
728	Human papillomavirus infection 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
729	Human papillomavirus infection 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
730	Human papillomavirus infection 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
731	Human papillomavirus infection 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
732	Human papillomavirus infection 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
733	Human papillomavirus infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
734	Human papillomavirus infection 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
735	Human papillomavirus infection 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
736	Human papillomavirus infection 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
737	Human papillomavirus infection 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
738	Human T-cell leukemia virus 1 infection 💬	[2] IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
739	Human T-cell leukemia virus 1 infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
740	Human T-cell leukemia virus 1 infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
741	Human T-cell leukemia virus 1 infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
742	Human T-cell leukemia virus 1 infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
743	Human T-cell leukemia virus 1 infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
744	Huntington disease 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
745	Huntington disease 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
746	Huntington disease 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
747	Huntington disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
748	Huntington disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
749	Huntington disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
750	Huntington disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
751	Hypertrophic cardiomyopathy 💬	[2] IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
752	Hypertrophic cardiomyopathy 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
753	Hypertrophic cardiomyopathy 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
754	IL-17 signaling pathway 💬	[4] CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
755	IL-17 signaling pathway 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
756	IL-17 signaling pathway 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
757	IL-17 signaling pathway 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
758	IL-17 signaling pathway 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
759	IL-17 signaling pathway 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
760	IL-17 signaling pathway 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
761	IL-17 signaling pathway 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
762	IL-17 signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
763	Inflammatory bowel disease 💬	[5] IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
764	Inflammatory bowel disease 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
765	Inflammatory bowel disease 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
766	Inflammatory mediator regulation of TRP channels 💬	[1] IL1B 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
767	Influenza A 💬	[5] CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
768	Influenza A 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
769	Influenza A 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
770	Influenza A 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
771	Influenza A 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
772	Influenza A 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
773	Influenza A 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
774	Influenza A 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
775	Influenza A 💬	[1] TLR7 💬	D02500 💬	Imiquimod	[2] 34, 51 💬
776	Influenza A 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
777	Insulin resistance 💬	[2] IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
778	Insulin resistance 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
779	Insulin resistance 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
780	Insulin resistance 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
781	Insulin resistance 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
782	Insulin resistance 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
783	Insulin signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
784	Insulin signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
785	Insulin signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
786	Insulin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
787	Insulin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
788	Insulin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
789	Insulin signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
790	Insulin signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
791	Insulin signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
792	Intestinal immune network for IgA production 💬	[2] IL10, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
793	Intestinal immune network for IgA production 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
794	JAK-STAT signaling pathway 💬	[1] CSF3R 💬	D03235 💬	Filgrastim	[33]  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
795	JAK-STAT signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
796	JAK-STAT signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
797	JAK-STAT signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
798	JAK-STAT signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
799	JAK-STAT signaling pathway 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
800	JAK-STAT signaling pathway 💬	[2] IL10, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
801	JAK-STAT signaling pathway 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
802	JAK-STAT signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
803	JAK-STAT signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
804	JAK-STAT signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
805	JAK-STAT signaling pathway 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
806	JAK-STAT signaling pathway 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
807	JAK-STAT signaling pathway 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
808	JAK-STAT signaling pathway 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
809	JAK-STAT signaling pathway 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
810	JAK-STAT signaling pathway 💬	[2] PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
811	JAK-STAT signaling pathway 💬	[2] PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
812	Kaposi sarcoma-associated herpesvirus infection 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
813	Kaposi sarcoma-associated herpesvirus infection 💬	[1] IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
814	Kaposi sarcoma-associated herpesvirus infection 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
815	Kaposi sarcoma-associated herpesvirus infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
816	Kaposi sarcoma-associated herpesvirus infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
817	Kaposi sarcoma-associated herpesvirus infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
818	Kaposi sarcoma-associated herpesvirus infection 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
819	Kaposi sarcoma-associated herpesvirus infection 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
820	Kaposi sarcoma-associated herpesvirus infection 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
821	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
822	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
823	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
824	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
825	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
826	Kaposi sarcoma-associated herpesvirus infection 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
827	Kaposi sarcoma-associated herpesvirus infection 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
828	Kaposi sarcoma-associated herpesvirus infection 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
829	Kaposi sarcoma-associated herpesvirus infection 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
830	Kaposi sarcoma-associated herpesvirus infection 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
831	Legionellosis 💬	[3] IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
832	Legionellosis 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
833	Legionellosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
834	Leishmaniasis 💬	[4] IL10, IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
835	Leishmaniasis 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
836	Leishmaniasis 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
837	Leishmaniasis 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
838	Leishmaniasis 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
839	Leishmaniasis 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
840	Leishmaniasis 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
841	Leishmaniasis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
842	Leishmaniasis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
843	Long-term depression 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
844	Long-term depression 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
845	Long-term depression 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
846	Long-term depression 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
847	Long-term depression 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
848	Long-term depression 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
849	Long-term potentiation 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
850	Long-term potentiation 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
851	Long-term potentiation 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
852	Long-term potentiation 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
853	Long-term potentiation 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
854	Long-term potentiation 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
855	Longevity regulating pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
856	Longevity regulating pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
857	Longevity regulating pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
858	Longevity regulating pathway - multiple species 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
859	Longevity regulating pathway - multiple species 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
860	Longevity regulating pathway - multiple species 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
861	Malaria 💬	[5] CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
862	Malaria 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
863	Malaria 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
864	Malaria 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
865	MAPK signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
866	MAPK signaling pathway 💬	[7] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
867	MAPK signaling pathway 💬	[7] BRAF, FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
868	MAPK signaling pathway 💬	[3] CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
869	MAPK signaling pathway 💬	[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
870	MAPK signaling pathway 💬	[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
871	MAPK signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
872	MAPK signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
873	MAPK signaling pathway 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
874	MAPK signaling pathway 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
875	MAPK signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D03218 💬	Axitinib	[1] 34 💬
876	MAPK signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D08881 💬	Cediranib	[1] 34 💬
877	MAPK signaling pathway 💬	[3] IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
878	MAPK signaling pathway 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
879	MAPK signaling pathway 💬	[2] KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
880	MAPK signaling pathway 💬	[2] KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
881	MAPK signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
882	MAPK signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
883	MAPK signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
884	MAPK signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
885	MAPK signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
886	MAPK signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
887	MAPK signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
888	MAPK signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
889	Measles 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
890	Measles 💬	[3] IL1A, IL1B, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
891	Measles 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
892	Measles 💬	[1] TLR7 💬	D02500 💬	Imiquimod	[2] 34, 51 💬
893	Melanogenesis 💬	[1] KIT 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
894	Melanogenesis 💬	[1] KIT 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
895	Melanogenesis 💬	[1] KIT 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
896	Melanogenesis 💬	[1] KIT 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
897	Melanogenesis 💬	[1] KIT 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
898	Melanogenesis 💬	[2] KIT, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
899	Melanogenesis 💬	[2] KIT, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
900	Melanogenesis 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
901	Melanogenesis 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
902	Melanogenesis 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
903	Melanoma 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
904	Melanoma 💬	[3] BRAF, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
905	Melanoma 💬	[3] BRAF, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
906	Melanoma 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
907	Melanoma 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
908	Melanoma 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
909	Melanoma 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
910	Melanoma 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
911	Melanoma 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
912	Melanoma 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
913	Melanoma 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
914	Melanoma 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
915	Melanoma 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
916	Melanoma 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
917	Melanoma 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
918	Melanoma 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
919	Metabolic pathways 💬	[4] ABAT, ALDH5A1, GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
920	Metabolic pathways 💬	[2] DHFR, DHFR2 💬	D00142 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
921	Metabolic pathways 💬	[2] DHFR, DHFR2 💬	D02115 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
922	Metabolic pathways 💬	[1] HMGCR 💬	D00359 💬	Lovastatin	[11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
923	Metabolic pathways 💬	[1] HMGCR 💬	D00434 💬	Simvastatin	[21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
924	Metabolic pathways 💬	[2] PTGS1, PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
925	Metabolic pathways 💬	[2] PTGS1, PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
926	Metabolic pathways 💬	[2] PTGS1, PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
927	Metabolic pathways 💬	[2] PTGS1, PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
928	Metabolic pathways 💬	[2] PTGS1, PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
929	Metabolic pathways 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
930	MicroRNAs in cancer 💬	[2] ABL1, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
931	MicroRNAs in cancer 💬	[2] ABL1, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
932	MicroRNAs in cancer 💬	[3] ABL1, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
933	MicroRNAs in cancer 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
934	MicroRNAs in cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
935	MicroRNAs in cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
936	MicroRNAs in cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
937	MicroRNAs in cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
938	MicroRNAs in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
939	MicroRNAs in cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
940	MicroRNAs in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
941	MicroRNAs in cancer 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
942	MicroRNAs in cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
943	MicroRNAs in cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
944	MicroRNAs in cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
945	MicroRNAs in cancer 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
946	MicroRNAs in cancer 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
947	MicroRNAs in cancer 💬	[2] PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
948	MicroRNAs in cancer 💬	[2] PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
949	MicroRNAs in cancer 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
950	MicroRNAs in cancer 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
951	MicroRNAs in cancer 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
952	MicroRNAs in cancer 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
953	MicroRNAs in cancer 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
954	MicroRNAs in cancer 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
955	MicroRNAs in cancer 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
956	MicroRNAs in cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
957	Mineral absorption 💬	[1] VDR 💬	D00188 💬	Cholecalciferol	[23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
958	Morphine addiction 💬	[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
959	mTOR signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
960	mTOR signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
961	mTOR signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
962	mTOR signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
963	mTOR signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
964	mTOR signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
965	mTOR signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
966	mTOR signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
967	mTOR signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
968	mTOR signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
969	mTOR signaling pathway 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
970	mTOR signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
971	Natural killer cell mediated cytotoxicity 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
972	Natural killer cell mediated cytotoxicity 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
973	Natural killer cell mediated cytotoxicity 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
974	Natural killer cell mediated cytotoxicity 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
975	Natural killer cell mediated cytotoxicity 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
976	Natural killer cell mediated cytotoxicity 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
977	Natural killer cell mediated cytotoxicity 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
978	Natural killer cell mediated cytotoxicity 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
979	Natural killer cell mediated cytotoxicity 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
980	Natural killer cell mediated cytotoxicity 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
981	Necroptosis 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
982	Necroptosis 💬	[3] IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
983	Necroptosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
984	Necroptosis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
985	Neuroactive ligand-receptor interaction 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬	D00514 💬	Dexmedetomidine	[12]  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
986	Neuroactive ligand-receptor interaction 💬	[3] ADRA2A, ADRA2B, ADRA2C 💬	D01205 💬	Dexmedetomidine	[12]  2 ,  4 ,  6 , 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
987	Neuroactive ligand-receptor interaction 💬	[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
988	Neurotrophin signaling pathway 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
989	Neurotrophin signaling pathway 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
990	Neurotrophin signaling pathway 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
991	Neurotrophin signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
992	Neurotrophin signaling pathway 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
993	Neurotrophin signaling pathway 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
994	Neurotrophin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
995	Neurotrophin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
996	Neurotrophin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
997	Neutrophil extracellular trap formation 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
998	Neutrophil extracellular trap formation 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
999	Neutrophil extracellular trap formation 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1000	Neutrophil extracellular trap formation 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1001	Neutrophil extracellular trap formation 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1002	Neutrophil extracellular trap formation 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1003	Neutrophil extracellular trap formation 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1004	Neutrophil extracellular trap formation 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1005	Neutrophil extracellular trap formation 💬	[1] TLR7 💬	D02500 💬	Imiquimod	[2] 34, 51 💬
1006	NF-kappa B signaling pathway 💬	[2] IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1007	NF-kappa B signaling pathway 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1008	NF-kappa B signaling pathway 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1009	NF-kappa B signaling pathway 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1010	NF-kappa B signaling pathway 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1011	NF-kappa B signaling pathway 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1012	NF-kappa B signaling pathway 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1013	NF-kappa B signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1014	NF-kappa B signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1015	Nicotine addiction 💬	[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1016	NOD-like receptor signaling pathway 💬	[4] CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1017	NOD-like receptor signaling pathway 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
1018	NOD-like receptor signaling pathway 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1019	NOD-like receptor signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1020	Non-alcoholic fatty liver disease 💬	[4] IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1021	Non-alcoholic fatty liver disease 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1022	Non-alcoholic fatty liver disease 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1023	Non-small cell lung cancer 💬	[1] ALK 💬	D10866 💬	Brigatinib	[1] 34 💬
1024	Non-small cell lung cancer 💬	[1] ALK 💬	D09731 💬	Crizotinib	[1] 34 💬
1025	Non-small cell lung cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1026	Non-small cell lung cancer 💬	[3] BRAF, RAF1, RET 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1027	Non-small cell lung cancer 💬	[3] BRAF, RAF1, RET 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1028	Non-small cell lung cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1029	Non-small cell lung cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1030	Non-small cell lung cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1031	Non-small cell lung cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1032	Non-small cell lung cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1033	Non-small cell lung cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1034	Non-small cell lung cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1035	Non-small cell lung cancer 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1036	Non-small cell lung cancer 💬	[1] RET 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1037	Non-small cell lung cancer 💬	[1] RET 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1038	One carbon pool by folate 💬	[2] DHFR, DHFR2 💬	D00142 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
1039	One carbon pool by folate 💬	[2] DHFR, DHFR2 💬	D02115 💬	Methotrexate	[35] 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬
1040	Oocyte meiosis 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1041	Oocyte meiosis 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1042	Oocyte meiosis 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1043	Osteoclast differentiation 💬	[1] CSF1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1044	Osteoclast differentiation 💬	[1] CSF1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1045	Osteoclast differentiation 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
1046	Osteoclast differentiation 💬	[3] IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1047	Osteoclast differentiation 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1048	Osteoclast differentiation 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1049	Osteoclast differentiation 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1050	Osteoclast differentiation 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1051	Osteoclast differentiation 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1052	Ovarian steroidogenesis 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1053	Ovarian steroidogenesis 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1054	Ovarian steroidogenesis 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1055	Ovarian steroidogenesis 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1056	Ovarian steroidogenesis 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1057	Ovarian steroidogenesis 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1058	Oxytocin signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1059	Oxytocin signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1060	Oxytocin signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1061	Oxytocin signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1062	Oxytocin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1063	Oxytocin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1064	Oxytocin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1065	Oxytocin signaling pathway 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1066	Oxytocin signaling pathway 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1067	Oxytocin signaling pathway 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1068	Oxytocin signaling pathway 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1069	Oxytocin signaling pathway 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1070	Oxytocin signaling pathway 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1071	Oxytocin signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1072	Oxytocin signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1073	Pancreatic cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1074	Pancreatic cancer 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1075	Pancreatic cancer 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1076	Pancreatic cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1077	Pancreatic cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1078	Pancreatic cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1079	Pancreatic cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1080	Pancreatic cancer 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1081	Pancreatic cancer 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1082	Pancreatic cancer 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1083	Pancreatic cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1084	Pancreatic cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1085	Pancreatic cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1086	Pancreatic cancer 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1087	Pancreatic cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1088	Parathyroid hormone synthesis, secretion and action 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1089	Parathyroid hormone synthesis, secretion and action 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1090	Parathyroid hormone synthesis, secretion and action 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1091	Parathyroid hormone synthesis, secretion and action 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1092	Parathyroid hormone synthesis, secretion and action 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1093	Parathyroid hormone synthesis, secretion and action 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1094	Parathyroid hormone synthesis, secretion and action 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1095	Parathyroid hormone synthesis, secretion and action 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1096	Parathyroid hormone synthesis, secretion and action 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1097	Parathyroid hormone synthesis, secretion and action 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1098	Parathyroid hormone synthesis, secretion and action 💬	[1] VDR 💬	D00188 💬	Cholecalciferol	[23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
1099	Parkinson disease 💬	[1] SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
1100	Parkinson disease 💬	[1] SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
1101	Parkinson disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
1102	Parkinson disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
1103	Parkinson disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
1104	Parkinson disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
1105	Pathogenic Escherichia coli infection 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1106	Pathogenic Escherichia coli infection 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1107	Pathogenic Escherichia coli infection 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1108	Pathogenic Escherichia coli infection 💬	[3] IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1109	Pathogenic Escherichia coli infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1110	Pathogenic Escherichia coli infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1111	Pathogenic Escherichia coli infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
1112	Pathogenic Escherichia coli infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
1113	Pathogenic Escherichia coli infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
1114	Pathogenic Escherichia coli infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
1115	Pathways in cancer 💬	[3] ABL1, KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1116	Pathways in cancer 💬	[3] ABL1, KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1117	Pathways in cancer 💬	[4] ABL1, KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1118	Pathways in cancer 💬	[1] ALK 💬	D10866 💬	Brigatinib	[1] 34 💬
1119	Pathways in cancer 💬	[1] ALK 💬	D09731 💬	Crizotinib	[1] 34 💬
1120	Pathways in cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1121	Pathways in cancer 💬	[7] BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1122	Pathways in cancer 💬	[7] BRAF, FLT3, FLT4, KIT, PDGFRB, RAF1, RET 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1123	Pathways in cancer 💬	[1] CSF3R 💬	D03235 💬	Filgrastim	[33]  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1124	Pathways in cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1125	Pathways in cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1126	Pathways in cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1127	Pathways in cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1128	Pathways in cancer 💬	[6] FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1129	Pathways in cancer 💬	[6] FLT3, FLT4, KIT, PDGFRA, PDGFRB, RET 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1130	Pathways in cancer 💬	[1] FLT4 💬	D03218 💬	Axitinib	[1] 34 💬
1131	Pathways in cancer 💬	[1] FLT4 💬	D08881 💬	Cediranib	[1] 34 💬
1132	Pathways in cancer 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
1133	Pathways in cancer 💬	[1] IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1134	Pathways in cancer 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1135	Pathways in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1136	Pathways in cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1137	Pathways in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1138	Pathways in cancer 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1139	Pathways in cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1140	Pathways in cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1141	Pathways in cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1142	Pathways in cancer 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1143	Pathways in cancer 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1144	Pathways in cancer 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1145	Pathways in cancer 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1146	Pathways in cancer 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1147	Pathways in cancer 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1148	Pathways in cancer 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1149	Pathways in cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1150	Pathways of neurodegeneration - multiple diseases 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1151	Pathways of neurodegeneration - multiple diseases 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1152	Pathways of neurodegeneration - multiple diseases 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1153	Pathways of neurodegeneration - multiple diseases 💬	[1] CSF1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1154	Pathways of neurodegeneration - multiple diseases 💬	[1] CSF1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1155	Pathways of neurodegeneration - multiple diseases 💬	[4] IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1156	Pathways of neurodegeneration - multiple diseases 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1157	Pathways of neurodegeneration - multiple diseases 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1158	Pathways of neurodegeneration - multiple diseases 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1159	Pathways of neurodegeneration - multiple diseases 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1160	Pathways of neurodegeneration - multiple diseases 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1161	Pathways of neurodegeneration - multiple diseases 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1162	Pathways of neurodegeneration - multiple diseases 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1163	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1164	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1165	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1166	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1167	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1168	Pathways of neurodegeneration - multiple diseases 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1169	Pathways of neurodegeneration - multiple diseases 💬	[1] SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
1170	Pathways of neurodegeneration - multiple diseases 💬	[1] SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
1171	Pathways of neurodegeneration - multiple diseases 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1172	Pathways of neurodegeneration - multiple diseases 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
1173	Pathways of neurodegeneration - multiple diseases 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
1174	Pathways of neurodegeneration - multiple diseases 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
1175	Pathways of neurodegeneration - multiple diseases 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
1176	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] ALK 💬	D10866 💬	Brigatinib	[1] 34 💬
1177	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] ALK 💬	D09731 💬	Crizotinib	[1] 34 💬
1178	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1179	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1180	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1181	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1182	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1183	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1184	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1185	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1186	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1187	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1188	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1189	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1190	Pertussis 💬	[5] IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1191	Pertussis 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1192	Pertussis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1193	Phagosome 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
1194	Phagosome 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
1195	Phagosome 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
1196	Phagosome 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
1197	Phospholipase D signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1198	Phospholipase D signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1199	Phospholipase D signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1200	Phospholipase D signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1201	Phospholipase D signaling pathway 💬	[2] KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1202	Phospholipase D signaling pathway 💬	[2] KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1203	Phospholipase D signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1204	Phospholipase D signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1205	Phospholipase D signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1206	Phospholipase D signaling pathway 💬	[3] KIT, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1207	Phospholipase D signaling pathway 💬	[3] KIT, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1208	Phospholipase D signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1209	Phospholipase D signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1210	Phospholipase D signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1211	Phospholipase D signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1212	Phospholipase D signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1213	Phospholipase D signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1214	PI3K-Akt signaling pathway 💬	[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1215	PI3K-Akt signaling pathway 💬	[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1216	PI3K-Akt signaling pathway 💬	[1] CSF3R 💬	D03235 💬	Filgrastim	[33]  2 ,  6 , 11, 13, 16, 25, 26, 28, 34, 35, 36, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
1217	PI3K-Akt signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1218	PI3K-Akt signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1219	PI3K-Akt signaling pathway 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1220	PI3K-Akt signaling pathway 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1221	PI3K-Akt signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D03218 💬	Axitinib	[1] 34 💬
1222	PI3K-Akt signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D08881 💬	Cediranib	[1] 34 💬
1223	PI3K-Akt signaling pathway 💬	[6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1224	PI3K-Akt signaling pathway 💬	[6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1225	PI3K-Akt signaling pathway 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
1226	PI3K-Akt signaling pathway 💬	[1] IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1227	PI3K-Akt signaling pathway 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1228	PI3K-Akt signaling pathway 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1229	PI3K-Akt signaling pathway 💬	[2] KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1230	PI3K-Akt signaling pathway 💬	[2] KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1231	PI3K-Akt signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1232	PI3K-Akt signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1233	PI3K-Akt signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1234	PI3K-Akt signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1235	PI3K-Akt signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1236	PI3K-Akt signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1237	PI3K-Akt signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1238	PI3K-Akt signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1239	PI3K-Akt signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1240	Platelet activation 💬	[1] PTGS1 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1241	Platelet activation 💬	[1] PTGS1 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1242	Platelet activation 💬	[1] PTGS1 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1243	Platelet activation 💬	[1] PTGS1 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1244	Platelet activation 💬	[1] PTGS1 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1245	Platinum drug resistance 💬	[1] ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1246	Platinum drug resistance 💬	[1] ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1247	Platinum drug resistance 💬	[2] TOP2A, TOP2B 💬	D03899 💬	Doxorubicin	[4] 26, 28, 34, 331 💬
1248	Platinum drug resistance 💬	[2] TOP2A, TOP2B 💬	D00125 💬	Etoposide	[11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1249	Platinum drug resistance 💬	[2] TOP2A, TOP2B 💬	D04107 💬	Etoposide	[11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬
1250	Prion disease 💬	[4] IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1251	Prion disease 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1252	Prion disease 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1253	Prion disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
1254	Prion disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
1255	Prion disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
1256	Prion disease 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
1257	Progesterone-mediated oocyte maturation 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1258	Progesterone-mediated oocyte maturation 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1259	Progesterone-mediated oocyte maturation 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1260	Progesterone-mediated oocyte maturation 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1261	Progesterone-mediated oocyte maturation 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1262	Progesterone-mediated oocyte maturation 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1263	Prolactin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1264	Prolactin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1265	Prolactin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1266	Prolactin signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1267	Prolactin signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1268	Propanoate metabolism 💬	[1] ABAT 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1269	Prostate cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1270	Prostate cancer 💬	[3] BRAF, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1271	Prostate cancer 💬	[3] BRAF, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1272	Prostate cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1273	Prostate cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1274	Prostate cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1275	Prostate cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1276	Prostate cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1277	Prostate cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1278	Prostate cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1279	Prostate cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1280	Prostate cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1281	Prostate cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1282	Prostate cancer 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1283	Prostate cancer 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1284	Prostate cancer 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1285	Prostate cancer 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1286	Prostate cancer 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1287	Proteoglycans in cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1288	Proteoglycans in cancer 💬	[3] BRAF, KDR, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1289	Proteoglycans in cancer 💬	[3] BRAF, KDR, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1290	Proteoglycans in cancer 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1291	Proteoglycans in cancer 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1292	Proteoglycans in cancer 💬	[2] EGFR, ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1293	Proteoglycans in cancer 💬	[2] EGFR, ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1294	Proteoglycans in cancer 💬	[1] KDR 💬	D03218 💬	Axitinib	[1] 34 💬
1295	Proteoglycans in cancer 💬	[1] KDR 💬	D08881 💬	Cediranib	[1] 34 💬
1296	Proteoglycans in cancer 💬	[1] KDR 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1297	Proteoglycans in cancer 💬	[1] KDR 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1298	Proteoglycans in cancer 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1299	Proteoglycans in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1300	Proteoglycans in cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1301	Proteoglycans in cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1302	Proteoglycans in cancer 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1303	Proteoglycans in cancer 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1304	Proteoglycans in cancer 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1305	Proteoglycans in cancer 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1306	Proteoglycans in cancer 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1307	Proteoglycans in cancer 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1308	Proteoglycans in cancer 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1309	Proteoglycans in cancer 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1310	Rap1 signaling pathway 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1311	Rap1 signaling pathway 💬	[6] BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1312	Rap1 signaling pathway 💬	[6] BRAF, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1313	Rap1 signaling pathway 💬	[7] CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1314	Rap1 signaling pathway 💬	[7] CSF1, FLT1, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1315	Rap1 signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1316	Rap1 signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1317	Rap1 signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1318	Rap1 signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1319	Rap1 signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D03218 💬	Axitinib	[1] 34 💬
1320	Rap1 signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D08881 💬	Cediranib	[1] 34 💬
1321	Rap1 signaling pathway 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1322	Rap1 signaling pathway 💬	[2] KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1323	Rap1 signaling pathway 💬	[2] KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1324	Rap1 signaling pathway 💬	[3] KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1325	Rap1 signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1326	Rap1 signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1327	Rap1 signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1328	Rap1 signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1329	Rap1 signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1330	Ras signaling pathway 💬	[3] ABL1, KIT, PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1331	Ras signaling pathway 💬	[3] ABL1, KIT, PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1332	Ras signaling pathway 💬	[4] ABL1, KIT, PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1333	Ras signaling pathway 💬	[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1334	Ras signaling pathway 💬	[8] CSF1, FLT1, FLT3, FLT4, KDR, KIT, PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1335	Ras signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1336	Ras signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1337	Ras signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1338	Ras signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1339	Ras signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D03218 💬	Axitinib	[1] 34 💬
1340	Ras signaling pathway 💬	[3] FLT1, FLT4, KDR 💬	D08881 💬	Cediranib	[1] 34 💬
1341	Ras signaling pathway 💬	[6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1342	Ras signaling pathway 💬	[6] FLT3, FLT4, KDR, KIT, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1343	Ras signaling pathway 💬	[2] KDR, MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1344	Ras signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1345	Ras signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1346	Ras signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1347	Ras signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1348	Ras signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1349	Regulation of actin cytoskeleton 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1350	Regulation of actin cytoskeleton 💬	[3] BRAF, PDGFRB, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1351	Regulation of actin cytoskeleton 💬	[3] BRAF, PDGFRB, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1352	Regulation of actin cytoskeleton 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1353	Regulation of actin cytoskeleton 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1354	Regulation of actin cytoskeleton 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1355	Regulation of actin cytoskeleton 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1356	Regulation of actin cytoskeleton 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1357	Regulation of actin cytoskeleton 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1358	Regulation of actin cytoskeleton 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1359	Regulation of actin cytoskeleton 💬	[1] PDGFRA 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1360	Regulation of actin cytoskeleton 💬	[1] PDGFRA 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1361	Regulation of actin cytoskeleton 💬	[2] PDGFRA, PDGFRB 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1362	Regulation of actin cytoskeleton 💬	[2] PDGFRA, PDGFRB 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1363	Regulation of actin cytoskeleton 💬	[2] PDGFRA, PDGFRB 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1364	Regulation of lipolysis in adipocytes 💬	[2] PTGS1, PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1365	Regulation of lipolysis in adipocytes 💬	[2] PTGS1, PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1366	Regulation of lipolysis in adipocytes 💬	[2] PTGS1, PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1367	Regulation of lipolysis in adipocytes 💬	[2] PTGS1, PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1368	Regulation of lipolysis in adipocytes 💬	[2] PTGS1, PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1369	Regulation of lipolysis in adipocytes 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1370	Relaxin signaling pathway 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1371	Relaxin signaling pathway 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1372	Relaxin signaling pathway 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1373	Relaxin signaling pathway 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1374	Relaxin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1375	Relaxin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1376	Relaxin signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1377	Relaxin signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1378	Relaxin signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1379	Relaxin signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1380	Relaxin signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1381	Renal cell carcinoma 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1382	Renal cell carcinoma 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1383	Renal cell carcinoma 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1384	Renal cell carcinoma 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1385	Renal cell carcinoma 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1386	Renal cell carcinoma 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1387	Renal cell carcinoma 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1388	Renal cell carcinoma 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1389	Renal cell carcinoma 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1390	Retrograde endocannabinoid signaling 💬	[16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1391	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1392	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1393	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1394	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1395	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1396	Retrograde endocannabinoid signaling 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1397	Rheumatoid arthritis 💬	[5] CCL2, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1398	Rheumatoid arthritis 💬	[2] CSF1, FLT1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1399	Rheumatoid arthritis 💬	[2] CSF1, FLT1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1400	Rheumatoid arthritis 💬	[1] FLT1 💬	D03218 💬	Axitinib	[1] 34 💬
1401	Rheumatoid arthritis 💬	[1] FLT1 💬	D08881 💬	Cediranib	[1] 34 💬
1402	Rheumatoid arthritis 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1403	Rheumatoid arthritis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1404	Rheumatoid arthritis 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1405	Rheumatoid arthritis 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1406	RIG-I-like receptor signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1407	RIG-I-like receptor signaling pathway 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1408	RIG-I-like receptor signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1409	Salmonella infection 💬	[3] IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1410	Salmonella infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1411	Salmonella infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1412	Salmonella infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1413	Salmonella infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1414	Salmonella infection 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1415	Salmonella infection 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1416	Salmonella infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1417	Salmonella infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D01068 💬	Vinblastine	[1] 34 💬
1418	Salmonella infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08675 💬	Vinblastine	[1] 34 💬
1419	Salmonella infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D02197 💬	Vincristine	[3] 26, 34, 331 💬
1420	Salmonella infection 💬	[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬	D08679 💬	Vincristine	[3] 26, 34, 331 💬
1421	Serotonergic synapse 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1422	Serotonergic synapse 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1423	Serotonergic synapse 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1424	Serotonergic synapse 💬	[3] GABRB1, GABRB2, GABRB3 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1425	Serotonergic synapse 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1426	Serotonergic synapse 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1427	Serotonergic synapse 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1428	Serotonergic synapse 💬	[2] PTGS1, PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1429	Serotonergic synapse 💬	[2] PTGS1, PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1430	Serotonergic synapse 💬	[2] PTGS1, PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1431	Serotonergic synapse 💬	[2] PTGS1, PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1432	Serotonergic synapse 💬	[2] PTGS1, PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1433	Serotonergic synapse 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1434	Shigellosis 💬	[1] EGFR 💬	D03455 💬	Cetuximab	[5] 34, 51, 86, 89, 331 💬
1435	Shigellosis 💬	[1] EGFR 💬	D11251 💬	Icotinib	[1] 34 💬
1436	Shigellosis 💬	[1] EGFR 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1437	Shigellosis 💬	[1] EGFR 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1438	Shigellosis 💬	[2] IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1439	Shigellosis 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1440	Shigellosis 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1441	Shigellosis 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1442	Shigellosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1443	Shigellosis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1444	Signaling pathways regulating pluripotency of stem cells 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
1445	Signaling pathways regulating pluripotency of stem cells 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1446	Signaling pathways regulating pluripotency of stem cells 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1447	Signaling pathways regulating pluripotency of stem cells 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1448	Signaling pathways regulating pluripotency of stem cells 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1449	Signaling pathways regulating pluripotency of stem cells 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1450	Small cell lung cancer 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1451	Small cell lung cancer 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1452	Small cell lung cancer 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1453	Small cell lung cancer 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1454	Small cell lung cancer 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1455	Small cell lung cancer 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1456	Sphingolipid signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1457	Sphingolipid signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1458	Sphingolipid signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1459	Sphingolipid signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1460	Sphingolipid signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1461	Sphingolipid signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1462	Sphingolipid signaling pathway 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1463	Sphingolipid signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1464	Spinocerebellar ataxia 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1465	Spinocerebellar ataxia 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1466	Spinocerebellar ataxia 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1467	Staphylococcus aureus infection 💬	[1] IL10 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1468	Synaptic vesicle cycle 💬	[2] SLC6A2, SLC6A3 💬	D01296 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
1469	Synaptic vesicle cycle 💬	[2] SLC6A2, SLC6A3 💬	D04999 💬	Methylphenidate	[7]  6 , 13, 34, 84, 113, 179, 206 💬
1470	Systemic lupus erythematosus 💬	[2] IL10, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1471	Systemic lupus erythematosus 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1472	Systemic lupus erythematosus 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1473	T cell receptor signaling pathway 💬	[2] IL10, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1474	T cell receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1475	T cell receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1476	T cell receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1477	T cell receptor signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1478	T cell receptor signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1479	T cell receptor signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1480	T cell receptor signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1481	Taste transduction 💬	[6] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6 💬	D00549 💬	Propofol	[9]  6 , 21, 22, 34, 46, 75, 84, 98, 296 💬
1482	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬	D00354 💬	Lamotrigine	[5] 13, 34, 38, 114, 144 💬
1483	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬	D00358 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
1484	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬	D02086 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
1485	Taste transduction 💬	[3] SCN2A, SCN3A, SCN9A 💬	D08127 💬	Lidocaine	[12]  6 , 13, 34, 46, 51, 70, 84, 86, 168, 226, 231, 256 💬
1486	Taurine and hypotaurine metabolism 💬	[2] GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1487	Terpenoid backbone biosynthesis 💬	[2] FNTA, FNTB 💬	D03720 💬	Tipifarnib	[1] 34 💬
1488	Terpenoid backbone biosynthesis 💬	[1] HMGCR 💬	D00359 💬	Lovastatin	[11]  6 , 34, 46, 79, 156, 160, 195, 206, 263, 280, 310 💬
1489	Terpenoid backbone biosynthesis 💬	[1] HMGCR 💬	D00434 💬	Simvastatin	[21]  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
1490	TGF-beta signaling pathway 💬	[1] BMPR2 💬	D03779 💬	Dibotermin alfa	[1] 34 💬
1491	TGF-beta signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1492	TGF-beta signaling pathway 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1493	TGF-beta signaling pathway 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1494	Th17 cell differentiation 💬	[2] IL1B, IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1495	Th17 cell differentiation 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1496	Th17 cell differentiation 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1497	Th17 cell differentiation 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1498	Th17 cell differentiation 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1499	Thermogenesis 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1500	Thermogenesis 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1501	Thermogenesis 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1502	Thyroid cancer 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1503	Thyroid cancer 💬	[2] BRAF, RET 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1504	Thyroid cancer 💬	[2] BRAF, RET 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1505	Thyroid cancer 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1506	Thyroid cancer 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1507	Thyroid cancer 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1508	Thyroid cancer 💬	[1] RET 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1509	Thyroid cancer 💬	[1] RET 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1510	Thyroid hormone signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1511	Thyroid hormone signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1512	Thyroid hormone signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1513	Thyroid hormone signaling pathway 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1514	Thyroid hormone signaling pathway 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1515	Thyroid hormone signaling pathway 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1516	Thyroid hormone signaling pathway 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1517	Thyroid hormone signaling pathway 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1518	Tight junction 💬	[1] ERBB2 💬	D04024 💬	Lapatinib	[3] 34, 74, 75 💬
1519	Tight junction 💬	[1] ERBB2 💬	D08108 💬	Lapatinib	[3] 34, 74, 75 💬
1520	TNF signaling pathway 💬	[4] CCL2, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1521	TNF signaling pathway 💬	[1] CSF1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1522	TNF signaling pathway 💬	[1] CSF1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1523	TNF signaling pathway 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1524	TNF signaling pathway 💬	[1] MAP2K1 💬	D10604 💬	Binimetinib	[1] 34 💬
1525	TNF signaling pathway 💬	[1] MAP2K1 💬	D09666 💬	Selumetinib	[1] 34 💬
1526	TNF signaling pathway 💬	[1] MAP2K1 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1527	TNF signaling pathway 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1528	TNF signaling pathway 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1529	TNF signaling pathway 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1530	TNF signaling pathway 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1531	TNF signaling pathway 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1532	TNF signaling pathway 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1533	TNF signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1534	Toll-like receptor signaling pathway 💬	[2] IFNAR1, IFNAR2 💬	D02745 💬	Interferon alfa-2b	[2] 25, 34 💬
1535	Toll-like receptor signaling pathway 💬	[3] IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1536	Toll-like receptor signaling pathway 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1537	Toll-like receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1538	Toll-like receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1539	Toll-like receptor signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1540	Toll-like receptor signaling pathway 💬	[1] TLR7 💬	D02500 💬	Imiquimod	[2] 34, 51 💬
1541	Toll-like receptor signaling pathway 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1542	Toxoplasmosis 💬	[2] IL10, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1543	Toxoplasmosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1544	Toxoplasmosis 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1545	Transcriptional misregulation in cancer 💬	[1] FLT1 💬	D03218 💬	Axitinib	[1] 34 💬
1546	Transcriptional misregulation in cancer 💬	[1] FLT1 💬	D08881 💬	Cediranib	[1] 34 💬
1547	Transcriptional misregulation in cancer 💬	[2] FLT1, FLT3 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1548	Transcriptional misregulation in cancer 💬	[2] FLT1, FLT3 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1549	Transcriptional misregulation in cancer 💬	[1] FLT3 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1550	Transcriptional misregulation in cancer 💬	[1] FLT3 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1551	Transcriptional misregulation in cancer 💬	[1] IL6 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1552	Transcriptional misregulation in cancer 💬	[1] IL6 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1553	Transcriptional misregulation in cancer 💬	[1] MET 💬	D10062 💬	Cabozantinib	[1] 34 💬
1554	Tuberculosis 💬	[5] IL10, IL1A, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1555	Tuberculosis 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1556	Tuberculosis 💬	[1] RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1557	Tuberculosis 💬	[1] RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1558	Tuberculosis 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1559	Tuberculosis 💬	[1] VDR 💬	D00188 💬	Cholecalciferol	[23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
1560	Type I diabetes mellitus 💬	[2] GAD1, GAD2 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1561	Type I diabetes mellitus 💬	[3] IL1A, IL1B, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1562	Type I diabetes mellitus 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1563	Type I diabetes mellitus 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1564	Type II diabetes mellitus 💬	[1] CACNA1G 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1565	Type II diabetes mellitus 💬	[1] MTOR 💬	D02714 💬	Everolimus	[9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
1566	Type II diabetes mellitus 💬	[1] MTOR 💬	D00753 💬	Sirolimus	[40]  2 ,  6 , 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 127, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 💬
1567	Type II diabetes mellitus 💬	[1] MTOR 💬	D06068 💬	Temsirolimus	[4] 13, 34, 89, 331 💬
1568	Type II diabetes mellitus 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1569	Type II diabetes mellitus 💬	[1] TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1570	Type II diabetes mellitus 💬	[1] TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1571	Valine, leucine and isoleucine degradation 💬	[1] ABAT 💬	D00399 💬	Valproic acid	[16]  2 ,  3 ,  5 ,  6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
1572	Vascular smooth muscle contraction 💬	[1] BRAF 💬	D10064 💬	Dabrafenib	[1] 34 💬
1573	Vascular smooth muscle contraction 💬	[2] BRAF, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1574	Vascular smooth muscle contraction 💬	[2] BRAF, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1575	Vascular smooth muscle contraction 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1576	Vascular smooth muscle contraction 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1577	Vascular smooth muscle contraction 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1578	VEGF signaling pathway 💬	[1] KDR 💬	D03218 💬	Axitinib	[1] 34 💬
1579	VEGF signaling pathway 💬	[1] KDR 💬	D10062 💬	Cabozantinib	[1] 34 💬
1580	VEGF signaling pathway 💬	[1] KDR 💬	D08881 💬	Cediranib	[1] 34 💬
1581	VEGF signaling pathway 💬	[1] KDR 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1582	VEGF signaling pathway 💬	[1] KDR 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1583	VEGF signaling pathway 💬	[2] KDR, RAF1 💬	D06272 💬	Sorafenib	[2] 34, 86 💬
1584	VEGF signaling pathway 💬	[2] KDR, RAF1 💬	D08524 💬	Sorafenib	[2] 34, 86 💬
1585	VEGF signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1586	VEGF signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1587	VEGF signaling pathway 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1588	VEGF signaling pathway 💬	[1] PTGS2 💬	D00217 💬	Acetaminophen	[16]  3 ,  6 , 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬
1589	VEGF signaling pathway 💬	[1] PTGS2 💬	D00109 💬	Acetylsalicylic acid	[14] 13, 22, 34, 46, 49, 51, 86, 96, 97, 113, 158, 210, 231, 251 💬
1590	VEGF signaling pathway 💬	[1] PTGS2 💬	D00567 💬	Celecoxib	[9]  2 ,  3 , 34, 46, 70, 89, 161, 171, 271 💬
1591	VEGF signaling pathway 💬	[1] PTGS2 💬	D00903 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1592	VEGF signaling pathway 💬	[1] PTGS2 💬	D00904 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1593	VEGF signaling pathway 💬	[1] PTGS2 💬	D07816 💬	Diclofenac	[4] 13, 34, 46, 271 💬
1594	VEGF signaling pathway 💬	[1] VEGFA 💬	D06409 💬	Bevacizumab	[9] 13, 34, 85, 86, 87, 89, 227, 280, 331 💬
1595	VEGF signaling pathway 💬	[1] VEGFA 💬	D05697 💬	Ranibizumab	[4] 34, 166, 227, 301 💬
1596	Viral myocarditis 💬	[1] ABL1 💬	D01441 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1597	Viral myocarditis 💬	[1] ABL1 💬	D08066 💬	Imatinib	[12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
1598	Viral myocarditis 💬	[1] ABL1 💬	D08953 💬	Nilotinib	[5]  6 ,  8 , 34, 51, 86 💬
1599	Viral protein interaction with cytokine and cytokine receptor 💬	[4] CCL2, IL10, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1600	Viral protein interaction with cytokine and cytokine receptor 💬	[1] CSF1 💬	D06402 💬	Sunitinib	[2] 28, 34 💬
1601	Viral protein interaction with cytokine and cytokine receptor 💬	[1] CSF1 💬	D08552 💬	Sunitinib	[2] 28, 34 💬
1602	Viral protein interaction with cytokine and cytokine receptor 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1603	Viral protein interaction with cytokine and cytokine receptor 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬
1604	Yersinia infection 💬	[5] CCL2, IL10, IL1B, IL6, TNF 💬	D01583 💬	Pirfenidone	[10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
1605	Yersinia infection 💬	[2] IL6, TNF 💬	D08976 💬	Pomalidomide	[6] 28, 34, 51, 85, 227, 331 💬
1606	Yersinia infection 💬	[2] MAP2K1, MAP2K2 💬	D10604 💬	Binimetinib	[1] 34 💬
1607	Yersinia infection 💬	[2] MAP2K1, MAP2K2 💬	D09666 💬	Selumetinib	[1] 34 💬
1608	Yersinia infection 💬	[2] MAP2K1, MAP2K2 💬	D10175 💬	Trametinib	[4]  2 , 34, 279, 280 💬
1609	Yersinia infection 💬	[1] TNF 💬	D04687 💬	Lenalidomide	[7] 16, 26, 28, 34, 49, 284, 300 💬

Back to top